CD4 and graft versus host disease: As a result of initial donor CD4 T cell immune skewing, the two forms of GVHD exhibit strikingly divergent phenotypes at two weeks after donor cell transfer, as determined by either gene array [12] or flow cytometric analysis of splenic subsets that can be used as early surrogate markers for longer term phenotypes [13].